Powder: -20°C for 3 years | In solvent: -80°C for 1 year
NCC007 is a novel CKIα and CKIδ dual inhibitors by structural modification of N9 and C2 position of longdaysin.
説明 | NCC007 is a novel CKIα and CKIδ dual inhibitors by structural modification of N9 and C2 position of longdaysin. |
ターゲット&IC50 | CKIα:1.8 μM, CKIδ:3.6 μM |
In vitro | In vitro kinase assay showed that NCC007 inhibited CKIα and CKIδ with an IC50 of 1.8 and 3.6 μM. |
In vivo | NCC007 lengthened the period of mouse behavioral rhythms in vivo. |
分子量 | 447.5 |
分子式 | C22H28F3N7 |
CAS No. | 2342583-66-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 120 mg/mL (268.16 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
NCC007 2342583-66-6 Metabolism Stem Cells Casein Kinase inhibit NCC-007 Inhibitor NCC 007 inhibitor